ArticlePloS one2026
Innovative screening for OSAS in patients with head and neck cancer using the apneal application: Protocol for a prospective single-centre study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOSAS is a common yet underdiagnosed condition, particularly among patients with head and neck cancers (HNC). Anatomical changes caused by the tumor or its treatments-surgery, radiotherapy, or chemotherapy-can promote the onset of OSAS. However, fatigue in these patients is often attributed solely to the cancer treatment itself, which may delay appropriate diagnosis and management.
methodsThis prospective single-center study aims to assess the clinical feasibility of OSAS screening in patients with HNC using an innovative mobile application, Apneal, which uses smartphone sensors to detect nocturnal respiratory events through an artificial intelligence algorithm. Fifty adult patients diagnosed with HNC will be included. Each patient will perform two home-based overnight recordings using the Apneal application: one at the time of diagnosis and another six months after local treatment. Clinical and quality-of-life questionnaires will be completed. The estimated AHI will be compared with symptomatology and, if necessary, confirmed by a standard respiratory polygraphy. EXPECTED
resultsThe primary outcome is the proportion of patients for whom Apneal data are usable at the 6-month follow-up after treatment. Secondary objectives include assessing the incidence of OSAS according to the oncologic treatments received, identifying high-risk profiles, and evaluating the impact of OSAS on quality of life. DISCUSSION: This study could pave the way for a systematic, simple, low-cost, and non-invasive OSAS screening in patients with HNC. Ultimately, the goal is to enable a more personalized and comprehensive approach to care in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.